Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Food & Function|September 11, 2014
Digestion of microencapsulated oil powders: in vitro lipolysis and in vivo absorption from a food matrixMary Ann Augustin, Luz Sanguansri, Jenny Kartika Rusli, et al.
Asia Pacific Journal of Clinical Nutrition|March 22, 2019
Longitudinal nutritional changes in aging Australian womenEdward Hill, Allison Hodge, Peter Clifton, et al.
The Journal of Nutrition|December 20, 2013
Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acidsVanessa Danthiir, Diane Hosking, Nicholas R Burns, et al.
The American Journal of Clinical Nutrition|May 4, 2018
An 18-mo randomized, double-blind, placebo-controlled trial of DHA-rich fish oil to prevent age-related cognitive decline in cognitively normal older adultsVanessa Danthiir, Diane E Hosking, Ted Nettelbeck, et al.
Plos One|March 11, 2016
High-Density Lipoprotein-Associated miR-223 Is Altered after Diet-Induced Weight Loss in Overweight and Obese MalesFatiha Tabet, Luisa F Cuesta Torres, Kwok Leung Ong, et al.
The New England Journal of Medicine|May 28, 2024
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed HyperlipidemiaChristie M Ballantyne, Szilard Vasas, Masoud Azizad, et al.
The Journal of Nutrition|May 10, 2014
Mushrooms and Health Summit proceedingsMary Jo Feeney, Johanna Dwyer, Clare M Hasler-Lewis, et al.
Nature Medicine|April 7, 2026
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trialGerald F Watts, Russell Scott, David Sullivan, et al.
American Journal of Preventive Cardiology|June 15, 2026
Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR TrialsChristie M Ballantyne, Alexis Baass, Robert S Rosenson, et al.
Nature Medicine|August 25, 2023
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohortsGerald F Watts, Christian Schwabe, Russell Scott, et al.
Pageof 19